January 18, 2024
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.
January 17, 2024
After children experienced severe traumatic brain injury, the infusion of bone marrow mononuclear cells derived from the patient’s own bones led to less time spent in intensive care, less intense therapy, and, significantly, the structural preservation of white matter, which constitutes about half the total volume of the brain, according to new research from UTHealth Houston.
January 8, 2024
The body’s immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston.
December 22, 2023
Low-income U.S. veterans who are experiencing feelings of loneliness are more likely to purchase firearms, according to new research from UTHealth Houston.
December 18, 2023
The use of high-protease pancreatic replacement therapy demonstrated improvement in maladaptive behaviors, such as irritability, in preschool children with autism spectrum disorder (ASD), according to research conducted at 32 clinical sites, including UTHealth Houston.
December 5, 2023
An innovative lifestyle program offering free cooking classes, along with nutrition, exercise, and mindfulness education, for people at risk for chronic illnesses such as cardiovascular disease is open for enrollment at UTHealth Houston School of Public Health.
November 28, 2023
A five-year, $2 million grant to study the pharmacological effects of the areca nut, commonly known as the betel nut, was awarded to a UTHealth Houston researcher by the National Institute on Drug Abuse, part of the National Institutes of Health (NIH).
November 28, 2023
Though still a third-year student with McGovern Medical School at UTHealth Houston, Gabriela Grangeiro Cruz is already working to broaden the medical field’s, and the public’s, understanding of Alzheimer’s disease by studying ways to prevent the neurocognitive disorder, which affects 6 million people living in the U.S.
November 15, 2023
As part of a five-year, $3.9 million grant from the National Institutes of Health, Adriana Pérez, PhD, professor in the Department of Biostatistics and Data Science with UTHealth Houston School of Public Health in Austin, received a $1.9 million subcontract to determine the scope and drivers of low-value and unequal care for patients with Parkinson’s disease and Parkinson’s disease dementia.
November 14, 2023
McWilliams School of Biomedical Informatics at UTHealth Houston reached a funding landmark with 15 faculty members awarded 16 different grants totaling more than $31 million between August and October 2023. Each grant has a focus on medical artificial intelligence (AI) innovations and advancements in research or health care.
Previous Page
Page 7 of 26
Next Page
More headlines »